Subsequent options include a TNF-alpha antagonist, followed by rituximab or possibly abatacept; (2) Tocilizumab, a monoclonal antibody, inhibits interleukin-6 receptors. It is licensed in the European Union for patients with rheumatoid arthritis in whom other drugs have failed; (3) Clinical ...
原文出处:FDA approves the ACTPen for Roche’s Actemra, a single-dose, prefilled autoinjector for the treatment of rheumatoid arthritis, giant cell arteritis and two forms of juvenile arthritis---专业购:全球上市原研药品、参比剂我司是一所专采购全球的上市原研药品、参比剂等代购及代办一次性进口平台。
Tocilizumab (Actemra) for rheumatoid arthritis 来自 Semantic Scholar 喜欢 0 阅读量: 41 作者: N Listed 展开 摘要: [No authors listed] 展开 被引量: 47 年份: 2010 收藏 引用 批量引用 报错 分享 全部来源 免费下载 求助全文 Semantic Scholar 万方医学 NCBI NCBI ProQuest 查看更多 hsc...
Usual Adult Dose of Actemra for Rheumatoid Arthritis:IV: 4 mg/kg IV as a 60-minute single drip infusion once every 4 weeks, followed by an increase to 8 mg/kg IV given once every 4 weeks as a 60-minute single drip infusion based on clinical response, doses exceeding 800 mg per in...
“A method of treating rheumatoid arthritis (RA) in a patient comprising subcutaneously administering an anti-IL-6 receptor (IL-6R) antibody to the patient, wherein the anti-IL-6R antibody is administered as a fixed dose of 162 mg per dose every week or every two weeks, and wherein the...
ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs). ACTEMRA is indicated for the treatment of giant cell arteritis (GCA) in adult...
Indication: What Actemra is used for Actemra for subcutaneous injection is used to treat active moderate to severerheumatoid arthritis (RA). There are many different types of medicines used to treat RA. Your doctor, however, may have prescribed Actemra for another purpose. ...
Medication GuideInstructions for UsePrescribing InformationSpanish Prescribing InformationSafety SELECT A CONDITION: Moderate to Severe Rheumatoid Arthritis (RA) Systemic Sclerosis withEarly InterstitialLung Disease (SSc-ILD) Giant Cell Arteritis (GCA) ...
If you have rheumatoid arthritis (RA) or giant cell arteritis (GCA), or systemic sclerosis-interstitial lung disease (SSc-ILD) your healthcare provider should do blood tests 4 to 8 weeks after you start receiving ACTEMRA for the first 6 months and then every 3 months after that. If you ...
Actemra/RoActemra was the first humanised interleukin-6 (IL-6) receptor antagonist approved for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have used one or more disease-modifying antirheuma...